Skip to main content

aspirin, chlorpheniramine maleate, phenylephrine bitartrate 325 mg/1 / 2 mg/1 / 7.8 mg/1 Medicare Part D Coverage

Brand name: Alka-Seltzer Plus Cold Sparkling Original PowerFast Fizz
Dosage form
TABLET, EFFERVESCENT
Route
ORAL
0%
of Medicare Part D plans
cover aspirin, chlorpheniramine maleate, phenylephrine bitartrate

Find the cheapest plan for aspirin, chlorpheniramine maleate, phenylephrine bitartrate

Enter your ZIP code to compare every plan in your area side-by-side.

Compare Plans for aspirin, chlorpheniramine maleate, phenylephrine bitartrate →

Get aspirin, chlorpheniramine maleate, phenylephrine bitartrate Delivered to Your Door

Compare prices and get discounts from trusted online pharmacies

DrugCovered may earn commissions from pharmacy purchases. Prices and availability vary. Always consult your doctor before starting or changing medications.

Alternative Medications in the Same Drug Class

Other drugs in the Antiplatelet Agents that Medicare Part D plans also cover.

Frequently Asked Questions about aspirin, chlorpheniramine maleate, phenylephrine bitartrate

0% of Medicare Part D plans cover aspirin, chlorpheniramine maleate, phenylephrine bitartrate. Coverage varies by plan and geographic area.

Costs vary by plan. Enter your ZIP code above to see exact prices for plans in your area.

The tier placement for aspirin, chlorpheniramine maleate, phenylephrine bitartrate varies by plan. Compare plans to find the best tier for your medication.

0% of plans require prior authorization for aspirin, chlorpheniramine maleate, phenylephrine bitartrate. Prior authorization means your doctor must confirm the drug is medically necessary before the plan will cover it.

Medicare & Health Management Products

Weekly AM/PM Pill Organizer
Shop on Amazon
Medication Record Keeper
Shop on Amazon
Blood Pressure Monitor
Shop on Amazon
Portable Medication Bag
Shop on Amazon

As an Amazon Associate, DrugCovered may earn from qualifying purchases. Product recommendations are for informational purposes and do not constitute medical advice.

Coverage statistics based on CMS formulary data for plan year 2026. Data updated regularly. Methodology →